Literature DB >> 2829198

The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.

E R Mackow1, R D Shaw, S M Matsui, P T Vo, M N Dang, H B Greenberg.   

Abstract

The complete gene 4 nucleotide sequence was determined for rhesus rotavirus and each of 11 viral variants selected by neutralizing monoclonal antibodies. Gene 4 is 2362 bases in length and encodes a protein, VP3, of 776 amino acids with a calculated Mr of 86,500. A conserved trypsin cleavage site, located at amino acid 247, divides VP3 into VP8 and VP5. Neutralizing monoclonal antibodies directed at VP3 were used to select variants that escaped neutralization. Each variant contains a single gene 4 mutation that permits viral growth in the presence of the antibody. Variant mutations were identified in six distinct neutralization regions in VP8 and VP5. Five of the six neutralization regions were found in VP8. The VP8 regions were primarily associated with strain-specific or limited heterotypic rotavirus neutralization. One region was identified in VP5 by three monoclonal antibodies that neutralize a broad range of rotavirus serotypes. The VP5 neutralization region is largely hydrophobic and is similar to putative fusion sequences of Sindbis and Semliki Forest viruses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829198      PMCID: PMC279611          DOI: 10.1073/pnas.85.3.645

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Viral gastroenteritis.

Authors:  I H Holmes
Journal:  Prog Med Virol       Date:  1979

2.  Epitope-specific immune responses to rotavirus vaccination.

Authors:  R D Shaw; K J Fong; G A Losonsky; M M Levine; Y Maldonado; R Yolken; J Flores; A Z Kapikian; P T Vo; H B Greenberg
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

3.  Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores.

Authors:  J J Skehel; W K Joklik
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

4.  Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.

Authors:  M K Estes; D Y Graham; B B Mason
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

5.  Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.

Authors:  A R Kalica; H B Greenberg; R G Wyatt; J Flores; M M Sereno; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

6.  Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins.

Authors:  H Garoff; A M Frischauf; K Simons; H Lehrach; H Delius
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

7.  Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins.

Authors:  C M Rice; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1981-10-24       Impact factor: 16.971

9.  Mapping adenines, guanines, and pyrimidines in RNA.

Authors:  H Donis-Keller; A M Maxam; W Gilbert
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  116 in total

1.  Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells.

Authors:  M Nejmeddine; G Trugnan; C Sapin; E Kohli; L Svensson; S Lopez; J Cohen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.

Authors:  P R Dormitzer; H B Greenberg; S C Harrison
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Ionic strength- and temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization.

Authors:  Sandra Martin; Mathie Lorrot; Mounia Alaoui El Azher; Monique Vasseur
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

5.  Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability.

Authors:  Nina E Golantsova; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.

Authors:  D Y Chen; M K Estes; R F Ramig
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  Isolation and characterization of a novel reassortant between avian Ty-1 and simian RRV rotaviruses.

Authors:  D A Kool; S M Matsui; H B Greenberg; I H Holmes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

8.  Structural rearrangements in the membrane penetration protein of a non-enveloped virus.

Authors:  Philip R Dormitzer; Emma B Nason; B V V Prasad; Stephen C Harrison
Journal:  Nature       Date:  2004-08-26       Impact factor: 49.962

9.  Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina.

Authors:  R C Bellinzoni; J O Blackhall; N M Mattion; M K Estes; D R Snodgrass; J L LaTorre; E A Scodeller
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  Bovine rotavirus type detection by neutralizing monoclonal antibodies.

Authors:  E Cornaglia; Y Elazhary; B Talbot
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.